171 related articles for article (PubMed ID: 12574810)
1. A randomized trial of initial warfarin dosing based on simple clinical criteria.
Shine D; Patel J; Kumar J; Malik A; Jaeger J; Maida M; Ord L; Burrows G
Thromb Haemost; 2003 Feb; 89(2):297-304. PubMed ID: 12574810
[TBL] [Abstract][Full Text] [Related]
2. Initiation of warfarin therapy in elderly medical inpatients: a safe and accurate regimen.
Siguret V; Gouin I; Debray M; Perret-Guillaume C; Boddaert J; Mahé I; Donval V; Seux ML; Romain-Pilotaz M; Gisselbrecht M; Verny M; Pautas E
Am J Med; 2005 Feb; 118(2):137-42. PubMed ID: 15694897
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery.
Meijer K; Kim YK; Carter D; Schulman S
Thromb Haemost; 2011 Feb; 105(2):232-8. PubMed ID: 21173999
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.
Wong YM; Quek YN; Tay JC; Chadachan V; Lee HK
J Clin Pharm Ther; 2011 Oct; 36(5):585-91. PubMed ID: 21070296
[TBL] [Abstract][Full Text] [Related]
5. Optimal initial dose adjustment of warfarin in orthopedic patients.
Lenzini PA; Grice GR; Milligan PE; Gatchel SK; Deych E; Eby CS; Burnett RS; Clohisy JC; Barrack RL; Gage BF
Ann Pharmacother; 2007 Nov; 41(11):1798-804. PubMed ID: 17911206
[TBL] [Abstract][Full Text] [Related]
6. Retrospective evaluation of a method to predict fresh-frozen plasma dosage in anticoagulated patients.
Frazee LA; Bourguet CC; Gutierrez W; Elder-Arrington J; Elackattu AE; Haller NA
Am J Ther; 2008; 15(2):111-8. PubMed ID: 18356630
[TBL] [Abstract][Full Text] [Related]
7. Dosing options for decreasing the time to achieve therapeutic anticoagulation when reinitiating warfarin: a case series.
Schultz KT; Bungard TJ
Pharmacotherapy; 2011 Aug; 31(8):793-805. PubMed ID: 21923606
[TBL] [Abstract][Full Text] [Related]
8. Warfarin therapy: evolving strategies in anticoagulation.
Horton JD; Bushwick BM
Am Fam Physician; 1999 Feb; 59(3):635-46. PubMed ID: 10029789
[TBL] [Abstract][Full Text] [Related]
9. Vitamin K in anticoagulation therapy.
Hanslik T; Viboud C; Chadenat ML; Jubault V; Prinseau J
Lancet; 2001 Feb; 357(9256):637; author reply 638. PubMed ID: 11558516
[No Abstract] [Full Text] [Related]
10. [INTERNATIONAL NORMALIZED RATIO VALUES AND HEMORRHAGE IN HOSPITALIZED PATIENTS STARTING WARFARIN THERPY: AN OBSERVATIONAL STUDY].
Abadi U; Ellis MH
Harefuah; 2015 Aug; 154(8):490-3, 541-2. PubMed ID: 26480611
[TBL] [Abstract][Full Text] [Related]
11. A proposal for an individualized pharmacogenetics-based warfarin initiation dose regimen for patients commencing anticoagulation therapy.
Avery PJ; Jorgensen A; Hamberg AK; Wadelius M; Pirmohamed M; Kamali F;
Clin Pharmacol Ther; 2011 Nov; 90(5):701-6. PubMed ID: 22012312
[TBL] [Abstract][Full Text] [Related]
12. Optimizing the dose of three-factor prothrombin complex concentrate in traumatic brain injury patients on warfarin therapy.
Huynh TK; Costello JL; Rebuck JA
Pharmacotherapy; 2014 Mar; 34(3):260-4. PubMed ID: 24338807
[TBL] [Abstract][Full Text] [Related]
13. Effect of heart failure exacerbations on anticoagulation: a prospective, observational, pilot cohort study.
Ripley TL; Harrison D; Germany RE; Adamson PB
Clin Ther; 2010 Mar; 32(3):506-14. PubMed ID: 20399987
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Inpatient Versus Outpatient Initiation on Early Warfarin Dosing.
Kasner SE; Wang L; French B; Messe SR; Horenstein R; Mohler ER; Muldowney JA; Ellenberg J; Kimmel SE
Am J Cardiovasc Drugs; 2015 Aug; 15(4):267-74. PubMed ID: 26037731
[TBL] [Abstract][Full Text] [Related]
15. Optimization of inpatient warfarin therapy: impact of daily consultation by a pharmacist-managed anticoagulation service.
Dager WE; Branch JM; King JH; White RH; Quan RS; Musallam NA; Albertson TE
Ann Pharmacother; 2000 May; 34(5):567-72. PubMed ID: 10852081
[TBL] [Abstract][Full Text] [Related]
16. Gene-based warfarin dosing compared with standard of care practices in an orthopedic surgery population: a prospective, parallel cohort study.
McMillin GA; Melis R; Wilson A; Strong MB; Wanner NA; Vinik RG; Peters CL; Pendleton RC
Ther Drug Monit; 2010 Jun; 32(3):338-45. PubMed ID: 20386359
[TBL] [Abstract][Full Text] [Related]
17. Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: an analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY) trial.
Van Spall HG; Wallentin L; Yusuf S; Eikelboom JW; Nieuwlaat R; Yang S; Kabali C; Reilly PA; Ezekowitz MD; Connolly SJ
Circulation; 2012 Nov; 126(19):2309-16. PubMed ID: 23027801
[TBL] [Abstract][Full Text] [Related]
18. The hemostatic effects of warfarin titration in post CABG patients in comparison to placebo treatment.
Walenga JM; Hoppensteadt D; Pifarré R; Fox NL; Forman S; Hunninghake DB; Campeau L; Herd JA; Hoogwerf BJ; Hickey A; Probstfield JL; Terrin ML
J Thromb Thrombolysis; 2001 Apr; 11(2):143-9. PubMed ID: 11406729
[TBL] [Abstract][Full Text] [Related]
19. Patient factors that influence warfarin dose response.
White PJ
J Pharm Pract; 2010 Jun; 23(3):194-204. PubMed ID: 21507814
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.
Bussey HI; Bussey M; Bussey-Smith KL; Frei CR
Pharmacotherapy; 2013 Nov; 33(11):1136-46. PubMed ID: 24038412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
